SCHEMBL8259155

SCHEMBL8259155

CCC(=O)C1(c2ccccc2)CCN(C(C)(C)C)CC1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.57
OPRM1 P35372 7/20 0.55
KCNH2 Q12809 2/20 0.55
GRIN2D O15399 1/20 0.55
GRIN3B O60391 1/20 0.55
CHRM2 P08172 1/20 0.55
CHRM1 P11229 1/20 0.55
GRIN1 Q05586 1/20 0.55
GRIN2A Q12879 1/20 0.55
GRIN2B Q13224 1/20 0.55
GRIN2C Q14957 1/20 0.55
GRIN3A Q8TCU5 1/20 0.55
OPRD1 P41143 4/20 0.48
OPRK1 P41145 4/20 0.48
SLC22A1 O15245 1/20 0.48
SLC6A4 P31645 1/20 0.48
ADRA1A P35348 1/20 0.48
DRD3 P35462 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16979517 0.84 OPRM1 (0.62) OPRM1KCNH2GRIN2DGRIN3BCHRM2
SCHEMBL8261418 0.83 OPRM1 (0.60) OPRM1KCNH2GRIN2DGRIN3BCHRM2
SCHEMBL10274482 0.83 OPRM1 (0.67) SLC18A3OPRM1KCNH2OPRD1OPRK1
SCHEMBL27821098 0.82 SLC18A3 (0.55) SLC18A3OPRM1KCNH2OPRD1OPRK1
SCHEMBL2440768 0.82 SLC18A3 (0.58) SLC18A3OPRM1KCNH2OPRD1OPRK1
SCHEMBL8437630 0.82 OPRM1 (0.69) SLC18A3OPRM1KCNH2OPRD1OPRK1
SCHEMBL1309812 0.82 SLC18A3 (0.60) SLC18A3OPRM1KCNH2OPRD1OPRK1
SCHEMBL16418420 0.82 OPRM1 (0.63) OPRM1KCNH2GRIN2DGRIN3BCHRM2
Budipine SCHEMBL4634429 0.81 DRD3 (0.56) SLC18A3OPRM1KCNH2GRIN2DGRIN3B
SCHEMBL1309331 0.80 TSHR (0.60) SLC18A3OPRM1KCNH2OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275964-A1 CANNABINOID RECEPTOR LIGANDS AND USES THEREOF PFIZER, INC. 2007-11-29 US disclosed
US-7268133-B2 Cannabinoid receptor ligands and uses thereof PFIZER, INC. PATENT DEPARTMENT (US) 2007-09-11 US disclosed
US-20040214837-A1 Cannabinoid receptor ligands and uses thereof PFIZER INC. 2004-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214837-A1 Cannabinoid receptor ligands and uses thereof CNR1, CNR2, GPR18 SLC18A3 809/4885OPRM1 6/4885KCNH2 3034/4885
US-20070275964-A1 CANNABINOID RECEPTOR LIGANDS AND USES THEREOF CNR1, CNR2, GPR18 SLC18A3 741/4885OPRM1 7/4885KCNH2 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.